These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1460224)

  • 41. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Inflammatory breast cancer: clinical course, diagnosis and treatment].
    Borisov VI; Chkhikvadze TV
    Vopr Onkol; 2008; 54(1):86-9. PubMed ID: 18416065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose chemotherapy and autologous stem cell transplantation for breast cancer.
    Weaver CH; Birch R; Schwartzberg LS; West WH
    Cancer Treat Res; 1995; 76():59-85. PubMed ID: 7577345
    [No Abstract]   [Full Text] [Related]  

  • 48. Optimizing Adjuvant Chemotherapy and Surgery for Early- and Late-Stage Breast Cancer.
    Vaz-Luis I; Burstein HJ
    JAMA Oncol; 2016 Nov; 2(11):1399-1400. PubMed ID: 27631400
    [No Abstract]   [Full Text] [Related]  

  • 49. Autologous bone marrow and peripheral blood progenitor transplant for breast cancer.
    Triozzi PL
    Lancet; 1994 Aug; 344(8920):418-9. PubMed ID: 7914559
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of locally advanced breast cancer.
    Verma S; Clemons M; Fitzgerald B; Freedman O
    CMAJ; 2004 Aug; 171(3):219; author reply 221-2. PubMed ID: 15289404
    [No Abstract]   [Full Text] [Related]  

  • 51. Systemic Treatment and Surgery versus Systemic Treatment Alone for Metastatic Breast Cancer.
    Almeida GR; Silvinato A; Bernardo WM
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):710-719. PubMed ID: 32696882
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of locally advanced breast cancer.
    Mirchandani D; Haider K; Chalchal H
    CMAJ; 2004 Aug; 171(3):219-20; author reply 221-2. PubMed ID: 15289403
    [No Abstract]   [Full Text] [Related]  

  • 53. [Adjuvant and neoadjuvant systemic therapy of breast carcinoma].
    Schmid P; Possinger K
    Internist (Berl); 2002 Mar; 43(3):341-4, 347-53. PubMed ID: 11963719
    [No Abstract]   [Full Text] [Related]  

  • 54. Systemic treatments for inflammatory breast cancer.
    Yang CH; Cristofanilli M
    Breast Dis; 2005-2006; 22():55-65. PubMed ID: 16735787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast conservation in locally advanced breast cancer: lessons to be learned.
    Pierce LJ
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1175-7. PubMed ID: 8600104
    [No Abstract]   [Full Text] [Related]  

  • 56. Management of early breast cancer.
    Rubens RD
    BMJ; 1992 May; 304(6838):1361-4. PubMed ID: 1611338
    [No Abstract]   [Full Text] [Related]  

  • 57. Autologous bone marrow transplantation for breast cancer.
    Peters WP
    Curr Opin Oncol; 1992 Apr; 4(2):279-82. PubMed ID: 1591302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Old and new trends in the adjuvant treatment of early breast cancer.
    Goldhirsch A; Valagussa P
    Ann Oncol; 1991 May; 2(5):320-2. PubMed ID: 1954175
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of adjuvant systemic therapy on response to treatment after relapse.
    Rubens RD
    Cancer Treat Rev; 1993 Apr; 19 Suppl B():3-10. PubMed ID: 8481931
    [No Abstract]   [Full Text] [Related]  

  • 60. High-dose chemotherapy with ABMT for metastatic breast cancer.
    Martin M
    J Clin Oncol; 1992 Oct; 10(10):1653-4. PubMed ID: 1403046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.